Impact of HIF1a, Ki-67, CA-9, and GLUT1 Expression on Treatment Outcomes in Locally Advanced Cervical Cancer Patients Treated With Definitive Chemoradiation Therapy

2015 ◽  
Vol 93 (3) ◽  
pp. E289
Author(s):  
T. Kim ◽  
B.M. Desai ◽  
T. Refaat ◽  
S. Sachdev ◽  
V. Parimi ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Locally Advanced ◽  
Chemoradiation Therapy ◽  
Advanced Cervical Cancer ◽  
Ki 67 ◽  
Locally Advanced Cervical Cancer ◽  
Definitive Chemoradiation ◽  
Glut1 Expression

Treatment outcomes of concurrent weekly carboplatin with radiation therapy in locally advanced cervical cancer patients

2011 ◽  
Vol 123 (3) ◽  
pp. 571-576 ◽  
Author(s):  
Kanyarat Katanyoo ◽  
Siriwan Tangjitgamol ◽  
Marisa Chongthanakorn ◽  
Thanatip Tantivatana ◽  
Sumonmal Manusirivithaya ◽  
...  
Keyword(s):  
Cervical Cancer ◽  
Radiation Therapy ◽  
Treatment Outcomes ◽  
Cancer Patients ◽  
Locally Advanced ◽  
Advanced Cervical Cancer ◽  
Locally Advanced Cervical Cancer

scholarly journals Oncothermia in HIV-Positive and -Negative Locally Advanced Cervical Cancer Patients in South Africa

2013 ◽  
Vol 2013 ◽  
pp. 1-3
Author(s):  
Carrie A. Strauss ◽  
Jeffrey A. Kotzen ◽  
Ans Baeyens ◽  
Irma Maré
Keyword(s):  
South Africa ◽  
Cervical Cancer ◽  
Cancer Patients ◽  
Standard Treatment ◽  
Locally Advanced ◽  
External Beam Radiation ◽  
Hiv Positive ◽  
Advanced Cervical Cancer ◽  
Treatment Toxicity ◽  
Locally Advanced Cervical Cancer

Aim. Investigate the clinical, economic, and cellular effects of the addition of oncothermia to standard treatment for HIV-positive and -negative locally advanced cervical cancer patients in public healthcare in South Africa. Objectives. Evaluate the effect that the addition of oncothermia has on local disease control, progression-free survival, overall survival at 2 years, treatment toxicity, quality of life, economic impact, and HIV status of participants. Radiobiology investigations will evaluate thermoradiosensitivity and the molecular markers for thermoradiosensitivity. Methodology. Phase III randomised clinical trial involving 236 HIV-negative and -positive stage IIb-III locally advanced cervical cancer patients. Treatment includes cisplatin, external beam radiation, and brachytherapy. The study group will receive oncothermia treatments. Participants will be monitored for two years after completion of treatment. Hypothesis. The addition of oncothermia to standard treatment protocols will result in improved clinical response without increasing treatment toxicity in HIV-positive patients or raising healthcare costs.

Sign in / Sign up

Export Citation Format

Share Document